Materialise Releases Latest Mimics Innovation Suite

Celebrating its 25th anniversary, global 3D Printing pioneer Materialise announces the launch of the latest Mimics Innovation Suite, including the Mimics® 18.0 and 3-matic® 10.0 software solutions. The new and improved tools increase user-friendliness, reduce segmentation time and make design and modeling even more realistic. It’s also possible to 3D print the results in full color. In addition, the visualization capabilities have been expanded with a fluoroscopy view and virtual X-ray simulation.

Fluoroscopy view of the mitral valve

The Mimics Innovation Suite offers a complete set of tools developed for biomedical professionals. With the addition of the ‘Fluoroscopy View’, healthcare professionals can simulate the angiographic view they would have during surgery and identify optimal c-arm angles for fluoroscopy for their region of interest. “This impressive new tool will be useful for our case planning as well as during conversations with physicians”, says Srinivasan Varahoor, Principal R&D Engineer at Medtronic. A second new visualization option is the ‘Virtual X-ray’* tool, which allows engineers to create virtual X-rays of projects to find the optimal angle for 2D/3D registration. This allows for an evaluation of the 3D position of bones and implants without a post-operative CT or MRI scan.

Another exciting and time-saving tool is the automated ‘Heart Segmentation’. This flexible, user-friendly solution allows for an effortless segmentation of the cardiovascular anatomy for advanced research and analyses. On a good quality dataset, segmentation now requires only a few mouse clicks rather than several hours of tedious work. In addition, the ‘Loft’ and ‘Sweep Loft’ tools make it easy to design benchtop models.

Mimics Innovation Suite 18.0 - New Release Out Now from Materialise NV on Vimeo.

With the advanced export options, it is now possible to add a logo to the design in only a few seconds and export it in *zpr format for 3D Printing in multiple colors. Holding such a model in one’s hand can greatly improve the understanding of the different anatomical structures.

Apart from software improvements, a new way to characterize the mitral valve has been added to the Mimics Innovation Suite. This new patent pending workflow allows for a detailed analysis of this complex anatomy, reduces the number of design iterations needed and permits more confident entry into clinical trials.

For more information on other improved features in this release of the Mimics Innovation Suite, please visit our website or contact the Mimics Innovation Team.

*Available in the Research Edition of the Mimics Innovation Suite only

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Materialise. (2019, March 18). Materialise Releases Latest Mimics Innovation Suite. AZoM. Retrieved on April 19, 2024 from https://www.azom.com/news.aspx?newsID=43872.

  • MLA

    Materialise. "Materialise Releases Latest Mimics Innovation Suite". AZoM. 19 April 2024. <https://www.azom.com/news.aspx?newsID=43872>.

  • Chicago

    Materialise. "Materialise Releases Latest Mimics Innovation Suite". AZoM. https://www.azom.com/news.aspx?newsID=43872. (accessed April 19, 2024).

  • Harvard

    Materialise. 2019. Materialise Releases Latest Mimics Innovation Suite. AZoM, viewed 19 April 2024, https://www.azom.com/news.aspx?newsID=43872.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.